Pharmaceutical giant Adcock Ingram has announced flat annual profits despite a significant recovery in the second half of its financial year. This was buoyed by strong demand for its popular over-the-counter winter medicines. In a landmark move, the maker of household staples like Panado and Corenza-C is also set to delist from the Johannesburg Stock Exchange (JSE). This follows a…
Tag: Panado
-
Adcock Ingram to Delist Amidst Corporate Changes
Adcock Ingram, the pharmaceutical giant behind household brands such as Panado and Corenza-C, could delist from the Johannesburg Stock Exchange (JSE). This follows a significant deal between its majority shareholder, Bidvest, and Indian drugmaker Natco Pharma. The news saw Adcock’s share price surge by 24%. Under the terms of the agreement, Indian-listed Natco Pharma will acquire a significant minority stake…